Skip to main content
Caplight Logo









Neuro20 Technologies Corp.

Neuro20 Technologies Corp.

Private
Oldsmar, FloridaHealthcare & Life Scienceshttps://neuro20.com/

Last Round

Seed

May 1, 2022

Total Funding Raised

$1.31M

Company Overview

Neuro20 Technologies Corp. is a medical device company that develops and manufactures wearable neuromuscular stimulation systems for rehabilitation and physical performance.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sports & Fitness

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

electrical muscle stimulationEMSneuromuscular rehabilitationsmart wearable suitpatterned electrical muscle stimulationPEMSphysical therapy equipmentelectroceuticalsfunctional electrical stimulationFESrehab techneuromuscular electrical stimulationNMESsports performance technologywearable medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuro20 Technologies Corp. Comparables

Compare Neuro20 Technologies Corp. with similar companies based on industry and business-model similarity.

Neuro20 Technologies Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AxioBionics
78%
Wiemspro
74%
CIONIC
71%

Neuro20 Technologies Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 1, 2022

Key People

Founding team and executive leadership

Jana Schmitt

Founder COO

Founding Team

Neuro20 Technologies Corp. Investors

Notable investors and investment history

Neuro20 Technologies Corp. investors
InvestorRounds
IntuitiveXSeed
Tampa Bay Technology IncubatorSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 21, 2023

    Grew 25% QoQ, from 12 to 15 employees.

  • Nov 27, 2023

    Grew 36% QoQ, from 11 to 15 employees.

Recent news

Latest coverage and updates

  • partners_withJun 30, 2026

    Neuro20 Technologies Corp. partnered with Togetherwewalk on Jun 30th '26.

Neuro20 Technologies Corp. Filings

Explore SEC and related filing metadata, where available.

Neuro20 Technologies Corp. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neuro20 Technologies Corp.'s valuation, stock price, and market status.

Is Neuro20 Technologies Corp. a public or private company?

Neuro20 Technologies Corp. is a private company.

What is the current stock price of Neuro20 Technologies Corp.?

Neuro20 Technologies Corp. is a private company with no public stock price. No recent secondary market data is available.

How much is Neuro20 Technologies Corp. worth (valuation)?

Valuation information for Neuro20 Technologies Corp. is not publicly available.

Can I buy Neuro20 Technologies Corp. stock?

Neuro20 Technologies Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neuro20 Technologies Corp.'s last funding round?

Neuro20 Technologies Corp.'s most recent funding round was Seed on May 1, 2022.

Who are the main investors in Neuro20 Technologies Corp.?

Key investors in Neuro20 Technologies Corp. include IntuitiveX, Tampa Bay Technology Incubator.

Will Neuro20 Technologies Corp. IPO soon?

No public IPO plans have been announced for Neuro20 Technologies Corp..

How can I track Neuro20 Technologies Corp. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neuro20 Technologies Corp.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOldsmar, Florida
Employee Range6
Year Founded2020
Last FundingMay 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?